- Savings card offer is valid for Tresiba® FlexTouch® U-100 and U-200 and the U-100 vial
Savings for your commercially insured and Medicare Part D patients
Commercially insured patients
Medicare Part D patients
- Nearly 50% of Part D patients prescribed Tresiba® receive Low-Income Subsidy or Extra Help benefits1
- Average Medicare co-pays for Tresiba® are comparable with other branded basal insulins1,c
aResults based on average monthly patient out-of-pocket cost for Tresiba® 12-month rolling period from IQVIA LAAD, September 2020. Excludes cash-paying patients.
bEligibility and other restrictions apply.
cOther branded basal insulins include Basaglar®, Lantus®, Levemir®, and Toujeo®.